Patients with glaucoma currently continue to suffer from these unmet needs.
Adtech’s science and technology look to change this.
Long-acting delivery system would eliminate issue of poor patient compliance with topical glaucoma medications and avoid wash-out effects with multiple drops. Preservative free formulations are preferred.
More Effective 1st and 2nd Line Medications
Most patients progress to 2L and 3L medications, or drug rotation due to inability of 1L medication to maintain IOP at target level or because of disease progression.
Neuroprotective treatments demonstrating prevention / restoration of vision loss would address the greatest unmet need